miR-204&211和RUNX2调控对人间充质间质细胞命运的影响

IF 2
Regenerative Medicine Research Pub Date : 2017-01-01 Epub Date: 2017-12-05 DOI:10.1051/rmr/170004
Benedetto Sacchetti, Alessandro Fatica, Melissa Sorci, Antonio Sorrentino, Michele Signore, Annamaria Cerio, Federica Felicetti, Alessandra De Feo, Elvira Pelosi, Alessandra Caré, Edoardo Pescarmona, Jan Oxholm Gordeladze, Mauro Valtieri
{"title":"miR-204&211和RUNX2调控对人间充质间质细胞命运的影响","authors":"Benedetto Sacchetti,&nbsp;Alessandro Fatica,&nbsp;Melissa Sorci,&nbsp;Antonio Sorrentino,&nbsp;Michele Signore,&nbsp;Annamaria Cerio,&nbsp;Federica Felicetti,&nbsp;Alessandra De Feo,&nbsp;Elvira Pelosi,&nbsp;Alessandra Caré,&nbsp;Edoardo Pescarmona,&nbsp;Jan Oxholm Gordeladze,&nbsp;Mauro Valtieri","doi":"10.1051/rmr/170004","DOIUrl":null,"url":null,"abstract":"<p><p>MiR-204 and 211 enforced expression in murine mesenchymal stromal cells (MSCs) has been shown to induce adipogenesis and impair osteogenesis, through RUNX2 down-modulation. This mechanism has been suggested to play a role in osteoporosis associated with obesity. However, two further fundamental MSC functions, chondrogenesis and hematopoietic supporting activity, have not yet been explored. To this end, we transduced, by a lenti-viral vector, miR-204 and 211 in a model primary human MSC line, opportunely chosen among our MSC collection for displaying all properties of canonical bone marrow MSCs, except adipogenesis. Enforced expression of miR-204&211 in these cells, rescued adipogenesis, and inhibited osteogenesis, as previously reported in murine MSCs, but, surprisingly, also damaged cartilage formation and hematopoietic supporting activity, which were never explored before. RUNX2 has been previously indicated as the target of miR-204&211, whose down modulation is responsible for the switch from osteogenesis to adipogenesis. However, the additional disruption of chondrogenesis and hematopoietic supporting activity, which we report here, might depend on diverse miR-204&211 targets. To investigate this hypothesis, permanent RUNX2 knock-down was performed. Sh-RUNX2 fully reproduced the phenotypes induced by miR-204&211, confirming that RUNX2 down modulation is the major event leading to the reported functional modification on our MSCs. It seems thus apparent that RUNX2, a recognized master gene for osteogenesis, might rule all four MSC commitment and differentiation processes. Hence, the formerly reported role of miR204&211 and RUNX2 in osteoporosis and obesity, coupled with our novel observation showing inhibition of cartilage differentiation and hematopoietic support, strikingly resemble the clinical traits of metabolic syndrome, where osteoarthritis, osteoporosis, anaemia and obesity occur together. Our observations, corroborating and extending previous observations, suggest that miR-204&211-RUNX2 axis in human MSCs is possibly involved in the pathogenesis of this rapidly growing disease in industrialized countries, for possible therapeutic intervention to regenerate former homeostasis.</p>","PeriodicalId":42378,"journal":{"name":"Regenerative Medicine Research","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1051/rmr/170004","citationCount":"9","resultStr":"{\"title\":\"Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells.\",\"authors\":\"Benedetto Sacchetti,&nbsp;Alessandro Fatica,&nbsp;Melissa Sorci,&nbsp;Antonio Sorrentino,&nbsp;Michele Signore,&nbsp;Annamaria Cerio,&nbsp;Federica Felicetti,&nbsp;Alessandra De Feo,&nbsp;Elvira Pelosi,&nbsp;Alessandra Caré,&nbsp;Edoardo Pescarmona,&nbsp;Jan Oxholm Gordeladze,&nbsp;Mauro Valtieri\",\"doi\":\"10.1051/rmr/170004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>MiR-204 and 211 enforced expression in murine mesenchymal stromal cells (MSCs) has been shown to induce adipogenesis and impair osteogenesis, through RUNX2 down-modulation. This mechanism has been suggested to play a role in osteoporosis associated with obesity. However, two further fundamental MSC functions, chondrogenesis and hematopoietic supporting activity, have not yet been explored. To this end, we transduced, by a lenti-viral vector, miR-204 and 211 in a model primary human MSC line, opportunely chosen among our MSC collection for displaying all properties of canonical bone marrow MSCs, except adipogenesis. Enforced expression of miR-204&211 in these cells, rescued adipogenesis, and inhibited osteogenesis, as previously reported in murine MSCs, but, surprisingly, also damaged cartilage formation and hematopoietic supporting activity, which were never explored before. RUNX2 has been previously indicated as the target of miR-204&211, whose down modulation is responsible for the switch from osteogenesis to adipogenesis. However, the additional disruption of chondrogenesis and hematopoietic supporting activity, which we report here, might depend on diverse miR-204&211 targets. To investigate this hypothesis, permanent RUNX2 knock-down was performed. Sh-RUNX2 fully reproduced the phenotypes induced by miR-204&211, confirming that RUNX2 down modulation is the major event leading to the reported functional modification on our MSCs. It seems thus apparent that RUNX2, a recognized master gene for osteogenesis, might rule all four MSC commitment and differentiation processes. Hence, the formerly reported role of miR204&211 and RUNX2 in osteoporosis and obesity, coupled with our novel observation showing inhibition of cartilage differentiation and hematopoietic support, strikingly resemble the clinical traits of metabolic syndrome, where osteoarthritis, osteoporosis, anaemia and obesity occur together. Our observations, corroborating and extending previous observations, suggest that miR-204&211-RUNX2 axis in human MSCs is possibly involved in the pathogenesis of this rapidly growing disease in industrialized countries, for possible therapeutic intervention to regenerate former homeostasis.</p>\",\"PeriodicalId\":42378,\"journal\":{\"name\":\"Regenerative Medicine Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1051/rmr/170004\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regenerative Medicine Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1051/rmr/170004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/12/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regenerative Medicine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1051/rmr/170004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/12/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

摘要

小鼠间充质间质细胞(MSCs)中MiR-204和211的强制表达已被证明通过下调RUNX2诱导脂肪生成并损害骨生成。这一机制已被认为在与肥胖相关的骨质疏松症中发挥作用。然而,MSC的两个进一步的基本功能,软骨形成和造血支持活性,尚未被探索。为此,我们通过慢病毒载体在模型原代人MSC细胞系中转导miR-204和211,该细胞系是在我们的MSC收集中选择的,用于显示标准骨髓MSC的所有特性,除了脂肪生成。在这些细胞中强迫表达mir -204和211,可以挽救脂肪生成,抑制骨生成,正如之前在小鼠间充质干细胞中报道的那样,但令人惊讶的是,也会破坏软骨形成和造血支持活性,这在以前从未被探索过。RUNX2先前已被认为是miR-204&211的靶点,其下调负责从成骨到脂肪生成的转换。然而,我们在这里报道的对软骨形成和造血支持活性的额外破坏可能取决于不同的mir -204和211靶点。为了验证这一假设,进行了RUNX2的永久敲除。Sh-RUNX2完全复制了mir -204和211诱导的表型,证实RUNX2下调是导致我们的MSCs报道的功能修饰的主要事件。因此,RUNX2,一个公认的成骨主控基因,可能控制所有四个MSC承诺和分化过程。因此,先前报道的miR204&211和RUNX2在骨质疏松和肥胖中的作用,加上我们的新观察显示软骨分化和造血支持的抑制,与代谢综合征的临床特征惊人地相似,其中骨关节炎,骨质疏松症,贫血和肥胖同时发生。我们的观察结果证实并扩展了先前的观察结果,表明人类间质干细胞中的miR-204&211-RUNX2轴可能参与了工业化国家这种快速发展的疾病的发病机制,可能用于治疗干预以恢复以前的内稳态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells.

MiR-204 and 211 enforced expression in murine mesenchymal stromal cells (MSCs) has been shown to induce adipogenesis and impair osteogenesis, through RUNX2 down-modulation. This mechanism has been suggested to play a role in osteoporosis associated with obesity. However, two further fundamental MSC functions, chondrogenesis and hematopoietic supporting activity, have not yet been explored. To this end, we transduced, by a lenti-viral vector, miR-204 and 211 in a model primary human MSC line, opportunely chosen among our MSC collection for displaying all properties of canonical bone marrow MSCs, except adipogenesis. Enforced expression of miR-204&211 in these cells, rescued adipogenesis, and inhibited osteogenesis, as previously reported in murine MSCs, but, surprisingly, also damaged cartilage formation and hematopoietic supporting activity, which were never explored before. RUNX2 has been previously indicated as the target of miR-204&211, whose down modulation is responsible for the switch from osteogenesis to adipogenesis. However, the additional disruption of chondrogenesis and hematopoietic supporting activity, which we report here, might depend on diverse miR-204&211 targets. To investigate this hypothesis, permanent RUNX2 knock-down was performed. Sh-RUNX2 fully reproduced the phenotypes induced by miR-204&211, confirming that RUNX2 down modulation is the major event leading to the reported functional modification on our MSCs. It seems thus apparent that RUNX2, a recognized master gene for osteogenesis, might rule all four MSC commitment and differentiation processes. Hence, the formerly reported role of miR204&211 and RUNX2 in osteoporosis and obesity, coupled with our novel observation showing inhibition of cartilage differentiation and hematopoietic support, strikingly resemble the clinical traits of metabolic syndrome, where osteoarthritis, osteoporosis, anaemia and obesity occur together. Our observations, corroborating and extending previous observations, suggest that miR-204&211-RUNX2 axis in human MSCs is possibly involved in the pathogenesis of this rapidly growing disease in industrialized countries, for possible therapeutic intervention to regenerate former homeostasis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Regenerative Medicine Research
Regenerative Medicine Research MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
0
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信